11/2024. INMUNOTEK Featured in Financial Times Ranking
INMUNOTEK has been recognized as one of the 300 European companies championing long-term growth in the Financial Times special report.
The Financial Times and Statista have identified the companies in Europe that have demonstrated organic revenue growth over the past decade. Those companies with the highest sustained growth between 2013 and 2023 have been included in a new Financial Times–Statista ranking.
With a CAGR (Compound Annual Growth Rate) of 16.38% (2013–2023), INMUNOTEK features in this selective ranking.
INMUNOTEK was previously included (2017) in the FT1000 (Financial Times–Statista), a ranking that identifies the 1,000 fastest-growing companies in Europe.










